The BCR-ABL fusion gene detection kit is a quantitative BCR-ABL1 p210 assay using digital PCR (dPCR).
• High Sensitivity:Sensitivity as high as 0.0032% (MR4.5), higher sensitive than other qPCR kits commercially available.
• The accuracy of tests is accepted across laboratories according to WHO traceability.
This kit adopts fluorescence quantitative PCR method to design specific primers and probes on abl and bcr-abl fusion gene (including e13a2 and e14a2 fusion types), and standard curve through corresponding standard material was established. The copy number of abl and bcr-abl fusion gene was then analyzed by the combination of the standard curve and the Ct value. According to the calculation formula and the correction coefficient (CF) provided by the kit, the bcr-ablis value and Mr value are obtained to quantify samples.
• Diagnosis and Medication Guidance for CML Patients.
• Quantitative monitoring of MRD in CML patients.
• MR4/MR4.5 (0.0032%) measurement.
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D